MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma

Neuroblastoma (NB) is the most common extracranial solid tumor occurring in childhood. Amplification of the MYCN oncogene is associated with poor prognosis. Downregulation on NB cells of ligands recognized by Natural Killer (NK) cell-activating receptors, involved in tumor cell recognition and lysis...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoimmunology
Glavni autori: Brandetti, Elisa, Veneziani, Irene, Melaiu, Ombretta, Pezzolo, Annalisa, Castellano, Aurora, Boldrini, Renata, Ferretti, Elisa, Fruci, Doriana, Moretta, Lorenzo, Pistoia, Vito, Locatelli, Franco, Cifaldi, Loredana
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2017
Teme:
Brief Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486189/
https://ncbi.nlm.nih.gov/pubmed/28680748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1316439
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items